Importantly, the blockade of TNF resulted in an improvement of tumor survival in DSS-treated tumor-bearing mice after ICB therapy, unlike IL-6 neutralization, which harmed rather than improved ICB-enhanced anti-tumor responses. This evidence concerns the gene IL6 and neoplasm.